Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis

NCT02563327 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

53

Enrollment

FED

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Rifapentine
DRUG: Moxifloxacin
DRUG: Rifampin
DRUG: Isoniazid
DRUG: Pyrazinamide
DRUG: Ethambutol
DIETARY_SUPPLEMENT: Pyridoxine

Sponsor

Centers for Disease Control and Prevention

Collaborators

[object Object]